Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

River Thames high in antibiotic-resistant bacteria
Ninety per cent of antibiotics taken by people enter the sewage system after passing through the body.

Researchers call for a significant cut in antibiotic prescriptions

Scientists studying the effect of antibiotic prescriptions on the environment say there would need to be an 80 per cent fall in antibiotics entering the River Thames to avoid the development of antibiotic-resistant ‘superbugs’.

Researchers from the Centre for Ecology & Hydrology (CEH) modelled the effects of the development and spread of antibiotic-resistant bacteria in a river. They found that, across three-quarters of the River Thames, the antibiotics present were high enough for antibiotic-resistant bacteria to develop.

The study comes after England’s chief medical officer Professor Dame Sally Davies warned that antibiotic resistance could kill humans “before climate change does.”
 Results are published in the journal PLOS ONE.

“Rivers are a ‘reservoir’ for antibiotic-resistant bacteria which can quickly spread to people via water, soil, air, food and animals,” said Dr Andrew Singer of the Centre for Ecology & Hydrology. “Our beaches offer a similar risk. It has been shown that surfers are four times more likely to carry drug-resistant bacteria than non-surfers.”

Ninety per cent of antibiotics taken by people enter the sewage system after passing through the body, with around half ending up in rivers when the sewage is discharged. 


“The release of drugs and bugs into our rivers increases the likelihood of antibiotic-resistant genes being shared, either through mutation or ‘bacterial sex’,” explains Dr Singer.

“This is the first step towards the development of superbugs as the drugs used to fight them will no longer work. Environmental pollution from drugs and bugs is a serious problem that we need to find solutions to.”


Researchers say there are several possible solutions to cut the number of antibiotics that enter our rivers. These include reducing inappropriate prescriptions, taking preventative action so fewer medicines are needed in the first place and increased investment in the research and development of new wastewater treatment processes. 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.